Spotlight
Topic
Brand Insights
- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
New CEO for Amplyx Pharmaceuticals
January 06, 2017
Ciara Kennedy
Amplyx Pharmaceuticals (San Diego, CA) has appointed Ciara Kennedy, Ph.D., to president and chief executive officer and Karen Joy Shaw, Ph.D., to chief scientific officer (CSO). The company's former president and CEO, Mike Grey, has assumed the role of executive chairman of the Amplyx Board of Directors. Dr. Kennedy joined Amplyx as chief operating officer in October 2015. Prior to that, she served as vice president and cholestatic liver disease program head at Shire Pharmaceuticals, and as COO of Lumena Pharmaceuticals.
Related Videos
Related Content
